Solitary plasmocytoma of the cranium: Magnetic resonance imaging findings

Solitary plasmacytoma of cranium is extremely rare. It has a wide pathological spectrum and can be found in benign and malignant (multiple myeloma) forms. Its clinical features are mixed. A comprehensive examination and analysis are required, including radiological examination, immunoglobulin, biochemistry, urine Bence Jones protein test, and bone marrow evaluation for an accurate diagnosis. In this article, magnetic resonance imaging (MRI) findings of a 48-year-old female patient who presented to the clinic with the complaint of swelling in the frontal region and diagnosed as solitary plasmacytoma of cranium as a result of histopathological findings were presented.

PDF

___

1. Du Preez JH, Branca EP. Plasmacytoma of the skull: Case reports. Neurosurgery. 1991;29:902-6.

2. Singh AD, Chacko AG, Chacko G, Rajshekhar V. Plasma cell tumors of the skull. Surg Neurol. 2005; 64:434-8.

3. Mancardi GL, Mandybur TI. Solitary intracranial plasmacytoma. Cancer. 1983;51:2226-33.

4. Ma XJ, Li D, Wang L, et al. Clinical features, radiological profiles, and surgical outcomes of primary intracranial solitary plasmacytomas: a report of 17 cases and a pooled analysis of individual patient data. J Neurooncol. 2019;142:263-72.

5. Blade J, Fernandez de Larrea C, Rosinol L, et al. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol. 2011;29:3805-12.

6. Keren DF, Alexanian R, Goeken JA, et al.Tomar RH. Guidelines for clinical and laboratory evaluation patients with monoclonal gammopathies. Arch Pathol Lab Med. 1999;123:106-7.

7. Cerase A, Tarantino A, Gozzetti A. Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay. Neuroradiology. 2008;50:665-74.

8. Tirumani S.H, Shinagare A.B, Jagannathan J.P. MRI features of extramedullary myeloma. Am J Roentgenol. 2014;202:803-10.

9. Mele G, Pastore D. Efficacy of Carfilzomib, Lenalidomide, and Dexamethasone for Extramedullary Intracranial Localization of Multiple Myeloma. Case Rep Hematol. 2018;29:430.

10. Devoe CE, Li JY, Demopoulos AM. The successful treatment of a recurrent intracranial, dural-based plasmacytoma with lenalidomide. J Neurooncol. 2014; 119:217-20.